These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2474830)

  • 41. Co-expression of the hepatitis B surface and core antigens using baculovirus multiple expression vectors.
    Takehara K; Ireland D; Bishop DH
    J Gen Virol; 1988 Nov; 69 ( Pt 11)():2763-77. PubMed ID: 3053987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B virus envelope epitopes: gene assembly and expression in Escherichia coli of an immunologically reactive novel multiple-epitope polypeptide 1 (MEP-1).
    Kumar V; Bansal VJ; Rao KV; Jameel S
    Gene; 1992 Jan; 110(2):137-44. PubMed ID: 1371488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of three different recombinant hepatitis B virus core particles expressed in Escherichia coli.
    Maassen A; Rehfeldt A; Kiessig S; Ladhoff A; Höhne WE; Meisel H
    Arch Virol; 1994; 135(1-2):131-42. PubMed ID: 8198438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.
    Kazaks A; Lachmann S; Koletzki D; Petrovskis I; Dislers A; Ose V; Skrastina D; Gelderblom HR; Lundkvist A; Meisel H; Borisova G; Krüger DH; Pumpens P; Ulrich R
    Intervirology; 2002; 45(4-6):340-9. PubMed ID: 12602354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of hepatitis B virus e antigen in E. coli.
    Inada T; Misumi Y; Seno M; Kanezaki S; Shibata Y; Oka Y; Onda H
    Virus Res; 1989 Sep; 14(1):27-47. PubMed ID: 2683475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
    Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
    Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective expression of immunogenic, virus-like particle-derived antibody-binding epitopes.
    El Kholy S; Riedl P; Kwissa M; Reimann J; Schirmbeck R
    Intervirology; 2002; 45(4-6):251-9. PubMed ID: 12566707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of HIV-1 epitopes included in particles formed by human hepatitis B virus nucleocapsid protein].
    Isaguliants MG; Kadoshnikov IuP; Kalinina TI; Khuliakov IuE; Semiletov IuA; Smirnov VD; Wahren B
    Biokhimiia; 1996 Mar; 61(3):532-45. PubMed ID: 8724609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Bacterial synthesis of immunogenic epitopes of foot-and-mouth disease virus fused either to human necrosis factor or to hepatitis B core antigen].
    Nekrasova OV; Boĭchenko VE; Boldyreva EF; Borisova GP; Pumpen P; Perevozchikova NA; Korobko VG
    Bioorg Khim; 1997 Feb; 23(2):118-26. PubMed ID: 9157845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis B core-based virus-like particles to present heterologous epitopes.
    Roose K; De Baets S; Schepens B; Saelens X
    Expert Rev Vaccines; 2013 Feb; 12(2):183-98. PubMed ID: 23414409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Products of the "X" gene in hepatitis B and related viruses.
    Feitelson MA
    Hepatology; 1986; 6(2):191-8. PubMed ID: 2420692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Displaying Whole-Chain Proteins on Hepatitis B Virus Capsid-Like Particles.
    Heger-Stevic J; Kolb P; Walker A; Nassal M
    Methods Mol Biol; 2018; 1776():503-531. PubMed ID: 29869263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
    Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH
    Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of recombinant DNA techniques in the development of viral vaccines.
    Murray K
    Vaccine; 1988 Apr; 6(2):164-74. PubMed ID: 3291454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infection.
    Takayanagi M; Kakumu S; Ishikawa T; Higashi Y; Yoshioka K; Wakita T
    Virology; 1993 Sep; 196(1):138-45. PubMed ID: 8356791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of the N-terminal hydrophobic sequence of hepatitis B virus surface antigen on the folding and assembly of hybrid beta-galactosidase in Escherichia coli.
    Lee SC; Choi YC; Yu MH
    Eur J Biochem; 1990 Jan; 187(2):417-24. PubMed ID: 2105218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts.
    Jechlinger W; Haller C; Resch S; Hofmann A; Szostak MP; Lubitz W
    Vaccine; 2005 May; 23(27):3609-17. PubMed ID: 15855021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The core antigen of hepatitis B virus as a carrier for immunogenic peptides.
    Murray K; Shiau AL
    Biol Chem; 1999 Mar; 380(3):277-83. PubMed ID: 10223329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B virus core particles as epitope carriers.
    Pumpens P; Borisova GP; Crowther RA; Grens E
    Intervirology; 1995; 38(1-2):63-74. PubMed ID: 8666525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Demonstration of the immunogenicity of hepatitis B core antigen in a hepatitis B e antigen polypeptide (P19).
    Takahashi K; Imai M; Nomura M; Oinuma A; Machida A; Funatsu G; Miyakawa Y; Mayumi M
    J Gen Virol; 1981 Dec; 57(Pt 2):325-30. PubMed ID: 6172555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.